Pneumatic Compression Treatment For Upper Extremity Acquired Lymphedema
- Conditions
- Lymphedema
- Interventions
- Other: Exercise, Elevation, and Compression GarmentDevice: E0650 PCD with non-sequential waveformDevice: E0651 PCD with sequential, non-gradient waveformDevice: E0652 PCD with sequential, gradient waveformDevice: E0652 PCD with peristaltic pulse waveform
- Registration Number
- NCT00951067
- Lead Sponsor
- Boston Children's Hospital
- Brief Summary
The purpose of this study is to determine how well different treatments for acquired lymphedema work.
The study will compare 5 different non-invasive treatments for acquired lymphedema of the arm to see which treats lymphedema best.
- Detailed Description
This study will compare 5 non-invasive lymphedema treatments.
Patients will be assigned to either:
- A combination of arm exercises, arm elevation, and wearing of a compression garment every day
OR
- One of four possible pneumatic compression devices for just two hours every day.
Pneumatic compression devices are made up of an inflatable sleeve connected to a small controller unit that is plugged into the wall. They feel like having your blood pressure taken.
None of the treatments are experimental. None of the treatments are invasive. All the treatments are considered standard of care and are used in clinics throughout the United States. All of the treatments will be done at home.
The trial will last for 7 and 1/2 months and will require follow-up visits to monitor progress.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients diagnosed with acquired lymphedema of the arm.
- Refusal of consent
- Unlikely compliance with the research protocol
- Acute upper extremity DVT
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group A Exercise, Elevation, and Compression Garment Exercise, Elevation, and Garment Compression Group B E0650 PCD with non-sequential waveform Pneumatic Compression Device (B) Group C E0651 PCD with sequential, non-gradient waveform Pneumatic Compression Device (C) Group D E0652 PCD with sequential, gradient waveform Pneumatic Compression Device (D) Group E E0652 PCD with peristaltic pulse waveform Pneumatic Compression Device (E)
- Primary Outcome Measures
Name Time Method Arm Volume Arm volume will be measured at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts
- Secondary Outcome Measures
Name Time Method Infection (cellulitis) Presence of infection will be recorded at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts Quality of Life Survey Survey will be given at 2 weeks before treatment starts, day treatment begins, and then 1 month, 3 months, 6 months, and 7 months after treatment starts
Trial Locations
- Locations (1)
Children's Hospital Boston at Waltham
🇺🇸Waltham, Massachusetts, United States